Assignee
INCARDA THERAPEUTICS INC
US·12 granted patents·10 pending applications·44 citations·filing 2015–2023
Top patents by PatentIndex Score
22 records- 0195US12059414B2Kits and methods for induction of cardioversion in subjects with atrial arrhythmiasINCARDA THERAPEUTICS INC·Filed 2022·Granted Aug 13, 2024·4 cites·12 claims
- 0292US11020384B2Antiarrhythmic formulationINCARDA THERAPEUTICS INC·Filed 2020·Granted Jun 1, 2021·5 cites·28 claims
- 0391US11007185B2Antiarrhythmic formulationINCARDA THERAPEUTICS INC·Filed 2020·Granted May 18, 2021·4 cites·21 claims
- 0490US10744087B2Method to slow ventricular rateINCARDA THERAPEUTICS INC·Filed 2019·Granted Aug 18, 2020·4 cites·30 claims
- 0590US10441537B2Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2018·Granted Oct 15, 2019·4 cites·23 claims
- 0688US10045939B2Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2015·Granted Aug 14, 2018·6 cites·31 claims
- 0788US10010294B2Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillationINCARDA THERAPEUTICS INC·Filed 2017·Granted Jul 3, 2018·9 cites·20 claims
- 0885US10668015B2Unit aerosol doses for anticoagulationINCARDA THERAPEUTICS INC·Filed 2016·Granted Jun 2, 2020·3 cites·17 claims
- 0983US10660578B2Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillationINCARDA THERAPEUTICS INC·Filed 2018·Granted May 26, 2020·4 cites·18 claims
- 1081US11547663B2Unit aerosol doses for anticoagulationINCARDA THERAPEUTICS INC·Filed 2020·Granted Jan 10, 2023·1 cites·18 claims
- 1178US12576074B2Kits and methods for induction of cardioversion in subjects with atrial arrhythmiasINCARDA THERAPEUTICS INC·Filed 2023·Granted Mar 17, 2026·0 cites·24 claims
- 1276US2023092389A1Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1366US2020179278A1Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1466US2020179279A1Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1562US2018296480A1Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1662US2019060230A1Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1762US2018318213A1Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1860US2025332152A1Inhaled therapy for cardiac arrhythmiaINCARDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1960US2019083396A1Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administrationINCARDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2058US12576073B2Antiarrhythmic formulationINCARDA THERAPEUTICS INC·Filed 2022·Granted Mar 17, 2026·0 cites·21 claims
- 2157US2022241278A1Inhalable imatinib formulationINCARDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2247US2021228825A1Methods for diagnosing brugada syndrome using an aerosolINCARDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INCARDA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →